Showing 2441-2450 of 3223 results for "".
- BVI Medical Launches Educational Platform for Ophthalmology Professionalshttps://modernod.com/news/bvi-medical-launches-educational-platform-for-ophthalmology-professionals/2482639/BVI Medical announced the launch of EyeXchange Solutions, a platform designed to enhance vision care through comprehensive educational resources and clinical support. This initiative aims to empower surgical decision-making, enhance provider experiences, alleviate economic
- 4DMT Announces Positive Interim Data from 4D-150 SPECTRA Clinical Trial in DMEhttps://modernod.com/news/4dmt-announces-positive-interim-data-from-4d-150-spectra-clinical-trial-in-dme/2482620/4D Molecular Therapeutics announced topline interim data from Part 1 of its SPECTRA clinical trial evaluating 4D-150 for the treatment of diabetic macular edema (DME). The company said it has achieved alignment with the FDA on the registrational pathway for 4D-150 in DME, advancing its
- FDA Approves Zeiss MEL 90 Excimer Laserhttps://modernod.com/news/fda-approves-zeiss-mel-90-excimer-laser/2482611/Zeiss has received FDA approval for the MEL 90, giving the excimer laser technology simultaneous approval for all three major indications: myopia, hyperopia, and mixed astigmatism. The Zeiss MEL 90 fully integrates into the company's Corneal Refractive Workflow,
- Dry Eye Institute Launches 'DEI On Demand' and Kicks Off Inaugural Road Eventhttps://modernod.com/news/dry-eye-institute-launches-dei-on-demand-and-kicks-off-inaugural-road-event/2482605/The Dry Eye Institute (DEI), an educational program for optometrists and ophthalmologists specializing in advanced dry eye care, has announced that for the first time, the institute’s curriculum is now available online through 'DEI On Demand.' DEI also announced that
- Lumibird Medical Rebrands its Japanese Subsidiaryhttps://modernod.com/news/lumibird-medical-rebrands-its-japanese-subsidiary/2482598/Lumibird Medical has announced the rebranding of its Japanese subsidiary. Formerly known as Ellex Japan, the company will now operate under the name Lumibird Medical Japan, effective immediately. Founded in Osaka in 2003, the subsidiary has grown over the past two decades,&nbs
- National Eye Institute Study Revisits Role of Annexin-V Biomarker in Retinal Cell Degenerationhttps://modernod.com/news/national-eye-institute-study-revisits-role-of-annexin-v-biomarker-in-retinal-cell-degeneration/2482588/Recent findings from a National Eye Institute-led study shed new light on annexin-V, a widely used biomarker to track apoptosis and retinal cell death in eye disease. The study group identified that annexin-V also binds to immune cells, suggesting it may a have a role as a marker for ocular infla
- ViaLase and the John A. Moran Eye Center Partner to Accelerate Glaucoma Research and Innovationhttps://modernod.com/news/vialase-and-the-john-a-moran-eye-center-announce-research-partnership-to-accelerate-glaucoma-research-and-innovation/2482573/ViaLase announced a research partnership with the John A. Moran Eye Center at the University of Utah, home to the Alan S. Crandall Center for Glaucoma Innovation. The collaboration will explore aqueous outflow dynamics of ViaLase’s ViaLase laser procedure, utilizing Moran’s iPerf
- ARPA-H Announces Pioneering Investments to Reverse Blindnesshttps://modernod.com/news/arpa-h-announces-pioneering-investments-to-reverse-blindness/2482572/The Advanced Research Projects Agency for Health (ARPA-H) announced the teams to receive the first investments from its Transplantation of Human Eye Allografts (THEA) program. ARPA-H, an agency w
- OneSight EssilorLuxottica Foundation Partners with WHO on SPECS 2030 Initiativehttps://modernod.com/news/onesight-essilorluxottica-foundation-partners-with-who-on-specs-2030-initiative-1/2482570/The OneSight EssilorLuxottica Foundation has announced a collaboration with the World Health Organization (WHO) as a global partner in the SPECS 2030 initiative. This strategic alliance is set to accelerate progress toward the world’s first global target for effective refractive error cover
- AOAExcel Endorses Its First EHR System: Barti Softwarehttps://modernod.com/news/aoaexcel-endorses-its-first-ehr-system-barti-software/2482554/AOAExcel, a member-benefit and for-profit subsidiary of the American Optometric Association (AOA), has made a financial investment in Barti Software, a San Francisco-based eye care Electronic Health Records (EHR) company. In addition, AOAExcel has endorsed Barti Software, which is the first